Physician
Oncology
Dr. Dejka M. Araujo, MD
|
|
Give Review
Dejka Araujo is an expert in the field of Oncology. She went to University of Arkansas for Medical Sciences College of Medicine. University of Arkansas for Medical Sciences College of Medicine has a rank of 83 in research and a 35 in primary care Dejka M. Araujo is a published physician. She has 15 publications published. The most current publication "Phase I study of pazopanib and vorinostat: a therapeutic approach for inhibiting mutant p53-mediated angiogenesis and facilitating mutant p53 degradation." Dejka Araujo accepts Medicare payments and is registered with Medicare.gov.
Publications
- Phase I study of pazopanib and vorinostat: a therapeutic approach for inhibiting mutant p53-mediated angiogenesis and facilitating mutant p53 degradation.
- Analysis of Prognostic Factors Impacting Oncologic Outcomes After Neoadjuvant Tyrosine Kinase Inhibitor Therapy for Gastrointestinal Stromal Tumors.
- Management and outcome of 239 adolescent and adult rhabdomyoSarcoma patients.
- Efficacy of first-line doxorubicin and ifosfamide in myxoid lipoSarcoma.
- Genetic amplification of the vascular endothelial growth factor (VEGF) pathway genes, including VEGFA, in human osteosarcoma.
- Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and Malignant solitary fibrous tumor.
- Inhibiting the VEGF-VEGFR pathway in angioSarcoma, epithelioid hemangioendothelioma, and hemangiopericytoma/solitary fibrous tumor.
- Rare incidence of congestive Heart failure in gastrointestinal stromal tumor and other sarcoma patients receiving imatinib mesylate.
- New insights into the hemangiopericytoma/solitary fibrous tumor spectrum of Tumors.
- Fluorescence in situ hybridization is a useful ancillary diagnostic tool for extraskeletal myxoid chondroSarcoma.
- Ulcerative keratitis in gastrointestinal stromal tumor patients treated with perifosine.
- Adult versus Pediatric Neuroblastoma: The M.D. Anderson Cancer Center Experience.
- Targeted therapy by combined inhibition of the RAF and mTOR kinases in Malignant spindle cell neoplasm harboring the KIAA1549-BRAF fusion protein.
- The role of chemotherapy in advanced solitary fibrous tumors: a retrospective Analysis.
Procedures Preformed
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
University of Texas Health Science Center -
University of Alabama Medical Center -
University of Arkansas for Medical Sciences College of Medicine
Hospital
-
University of Texas M.D. Anderson Cancer Center
Drug Facts
| NPI NUMBER | 1932294345 | |
| NPPES Provider LastName | ARAUJO | |
| NPPES Provider FirstName | DEJKA | |
| NPPES Provider ZIPCode | 770304009 | |
| NPPES Provider State | TX | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 446.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 26.0 | |
| Percent Opioid Claims | 5.83 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1932294345 |
| Last Name Of The Provider | ARAUJO |
| First Name Of The Provider | DEJKA |
| View All |
Similar Doctors
|
|
Dr. Shreyaskumar R. Patel, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paolo Anderlini, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Richard P. Baltz, MD |
|
|
Dr. John J. Kavanagh, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. James C. Yao, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Maria A. Zarzour, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Julie A. Ellerhorst, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Werner A. Bleyer, MD
This Doctor is OpenDoctor Recommended.
|